好祖2015-06-07 15:11
$Avalanche Biotechnologies(AAVL)$ 四周前收出了一个morning star,现在再次打回前期颈线位。这只股票个人一直在关注,周五收出一根突破性中阳,短期上冲动力比较大查看全文
王伟CFA美股MCORLEO2015-06-16 05:15
$Avalanche Biotechnologies(AAVL)$ 一个数据结果打回一年前IPO原形,医药股风险较大,特别是重要数据发布的时候,止损啊,技术分析啊,这些都很难有效控制风险的,止损在盘后是没有用的。医药股个人建议还是看基本面和资本运作情况,非常不建议赌数据和报告,即使你赌对了十次,一次暴跌50%,不仅...查看全文
割资本主义羊毛2015-06-17 03:37
受$Avalanche Biotechnologies(AAVL)$ 影响,gt组全线回调,当然,$Celladon Corporation(CLDN)$ 作为垃圾股已免疫,垃圾股行情又添新成员$Avalanche Biotechnologies(AAVL)$
幸存的GT组员:$SPARK THERAPEUTICS INC(ONCE)$ $BLUEBIRD BIO INC(BLUE)$ $uniQure(QURE)$ $Applied Genetic...查看全文
割资本主义羊毛2015-06-16 08:07
$Avalanche Biotechnologies(AAVL)$ 研发药股即便有信心去赌数据,也只能用利润段拿到的利润去赌,比如aavl最近的利润段也有将近三成,如果加上每日刷盘操作,拿满三成以上没问题,赌输了也是零成本,赌赢了就让它翻好了。aavl今天的数据本来是个福字,有解读指出泡沫成分,存在明显争议,股价在一...查看全文
郑坚强2015-06-16 20:51
$Avalanche Biotechnologies(AAVL)$ 果然是mixed data,达到了primary endpoint,但是效果不显著,视敏度只增加了2.2,还出现了一个视网膜增厚的问题,昨天尾盘也是直接被拉到52,最后十几分钟解决战斗投行的评级也是各有不同:jeffies,piper jaffray依然给出了TP 50多,其他一些基本都是20...查看全文
美股马甲2015-06-18 09:29
$Avalanche Biotechnologies(AAVL)$ Piper Jaffray's Steven P. Breazzano maintained an Overweight rating and $52 target.查看全文
淡投2015-06-18 08:47
网页链接
did his medical training at Harvard’s Mass Eye & Ear Infirmary (ophthalmology), Stanford Hospital (internal medicine) and UCSF (pathology). it has 13% of portifolio in $Avalanche Biotechnologies(AAVL)$ based upon 3/31 filing查看全文
割资本主义羊毛2015-06-17 03:37
受$Avalanche Biotechnologies(AAVL)$ 影响,gt组全线回调,当然,$Celladon Corporation(CLDN)$ 作为垃圾股已免疫,垃圾股行情又添新成员$Avalanche Biotechnologies(AAVL)$
幸存的GT组员:$SPARK THERAPEUTICS INC(ONCE)$ $BLUEBIRD BIO INC(BLUE)$ $uniQure(QURE)$ $Applied Genetic...查看全文
郑坚强2015-06-16 20:51
$Avalanche Biotechnologies(AAVL)$ 果然是mixed data,达到了primary endpoint,但是效果不显著,视敏度只增加了2.2,还出现了一个视网膜增厚的问题,昨天尾盘也是直接被拉到52,最后十几分钟解决战斗投行的评级也是各有不同:jeffies,piper jaffray依然给出了TP 50多,其他一些基本都是20...查看全文
$Avalanche Biotechnologies(AAVL)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-01-23 AccNo: 0001144204-17-003407 Size: 48 KB 网页链接
$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2016-12-09 AccNo: 0001193125-16-789773 Size: 15 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接
$Avalanche Biotechnologies(AAVL)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-08 AccNo: 0001564590-16-028352 Size: 7 MB 网页链接
$Avalanche Biotechnologies(AAVL)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-08 AccNo: 0001564590-16-028352 Size: 7 MB 网页链接
$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2016-11-08 AccNo: 0001193125-16-762980 Size: 70 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2016-11-08 AccNo: 0001193125-16-762980 Size: 70 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2016-11-04 AccNo: 0001193125-16-760211 Size: 15 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2016-10-14 AccNo: 0001193125-16-738145 Size: 37 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 7.0...
$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2016-10-13 AccNo: 0001193125-16-737669 Size: 4 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Avalanche Biotechnologies(AAVL)$ CT ORDER - Confidential treatment order Filed: 2016-10-11 AccNo: 9999999997-16-026367 Size: 11 KB 网页链接